The assessment of psychological resilience can facilitate an understanding of how patients utilize internal and external resources to adapt to adversities, traumas, significant life stressors, and disease treatment. At present, the unity of self-reported scales for assessing the psychological resilience of cancer patients remains controversial. Furthermore, it lacks the integration and standardized evaluation of scale measurement properties, and the selection of evaluation tools lacks evidence-based evidence.

To systematically assess the measurement properties of a psychological resilience evaluation tool for cancer patients and critically examine the study's methodological quality, therefore to provide a reference for healthcare professionals in selecting a high-quality assessment tool.

A systematic search of databases like PubMed, Embase, Web of Science, Cochrane Library, CINAHL, CNKI, VIP, CBM, and Wanfang Data was conducted for literature related to the evaluation of the measurement properties of the Cancer Psychological Resilience Scale. The search was done within the time frame of the database's creation to 2023-02-14. All identified articles were rated by two independent assessors following the COSMIN guidelines.

Thirteen studies were included, and among the nine cancer psychological resilience tools were the 10-item Connor-Davidson Resilience Scale (CD-RISC-10), the Resilience Scale Specific to Cancer (RS-SC), the 10-item Resilience Scale Specific to Cancer (RS-SC-10), the 14-item Resilience Scale (RS-14), the Brief Resilient Coping Scale (BRCS), the SV-RES Resilience Scale (SV-RES), the Ego-Resiliency Scale (ER89-R12), the Pain Resilience Scale (PRS), and the Shift and Persist Questionnaire. All scales—aside from the RS-SC-10, which suggested a "C" because of its poor cross-cultural validity—were rated "B" because of their ambiguous content validity and differing levels of evidence.

This systematic review provides an overview of psychological resilience assessment tools used in cancer patients. The RS-SC stands out as being one of the most robust instruments for measuring psychological resilience in patients. Evidence needs to be generated and used in the clinical setting.

心理弹性的评估能协助了解患者面临逆境、创伤等生活重大压力及疾病治疗等问题时，运用内外资源调试适应的过程。国内外目前可用来评估癌症心理弹性的量表多为自我报告形式且类别繁多，但暂无测量癌症心理弹性的金标准，且缺乏量表测量属性的整合及标准化评价，评估工具的选择缺乏循证依据。

系统评价癌症患者心理弹性评估工具的测量学属性及研究的方法学质量，为医护人员选择高质量的评估工具提供参考。

系统检索PubMed、Embase、Web of Science、Cochrane Library、CINAHL、中国知网、维普网、中国生物医学文献数据库、万方数据知识服务平台中与癌症心理弹性量表测量学属性评价有关的中英文文献，检索时限从建库至2023-02-14。2名研究者分别独立筛选文献、提取资料。依据健康测量工具选择的共识标准（COSMIN）系统评价指南，采用偏倚风险清单及质量标准评定量表评价测量学特性并形成最终的推荐意见。

共纳入13项研究，包含9个癌症心理弹性工具，分别为10项Connor-Davidson心理弹性量表（CD-RISC-10）、癌症心理弹性量表（RS-SC）、10项简短癌症心理弹性量表（RS-SC-10）、14项心理弹性量表（RS-14）、简明弹性应对量表（BRCS）、SV-RES心理弹性量表（SV-RES）、修订自我复原力量表（ER89-R12）、疼痛心理韧性量表（PRS）、转变和坚持问卷（SPQ），研究均未报告评估工具的反应度及测量误差。由于内容效度皆为不确定，证据质量等级为高等或以下，8个量表均为B级推荐；因跨文化效度为不充分且证据质量为高等，RS-SC-10为C级推荐。

本研究纳入的心理弹性评估工具的测量学特性均不完善，与其他8个量表相比，RS-SC的测量学属性评价较为全面，信效度较好，可暂时被推荐使用，但有待进一步深入验证。